Weekly Vet Report: FDA approves feline hypertension drug, injectable BOAS therapy shows early promise, and more - DVM360
8/10The FDA has approved a new drug for feline hypertension, marking a significant advancement in treating this common condition in cats. Additionally, early promising results have emerged for an injectable therapy targeting Brachycephalic Obstructive Airway Syndrome (BOAS) in dogs, potentially expanding treatment options for this respiratory condition.
